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To the Editor: The fungus Apo-
physomyces elegans (order Mucorales) 
is a thermotolerant species that causes 
severe infections among humans. In 
contrast to other fungi that cause zy-
gomycosis, which have a worldwide 
distribution and are rarely found in 
immunocompetent hosts, A. elegans 
has been reported mainly in areas with 
warm climates as an emerging patho-
gen that causes mostly cutaneous in-
fections after injury to the skin (1). 
This fungus was discovered in 1979 
(2) and until recently was considered 
the only species in the genus.
A polyphasic study of clinical and 
environmental strains of A. elegans, 
including analysis of several genes, 
showed that the genus contained 4 
well-characterized species (3). Of 
16 isolates tested in this study, only 
2 from soil in India were A. elegans. 
Most of the isolates were A. variabi-
lis. The incidence of A. variabilis in 
humans is unknown and difﬁ  cult to 
ascertain because most cases had iso-
lates that were not properly preserved. 
These fungi usually cause necrotizing 
fasciitis, but rhino-orbito-cerebral or 
renal infections have also been report-
ed (1). Whether these infections are 
produced by different Apophysomyces 
spp., have different responses to an-
tifungal drugs, or have differences in 
virulence is unknown.
To assess incidence of Apophy-
somyces spp. in a tertiary hospital 
(Government Medical College Hospi-
tal, Chandigarh, India), which usually 
receives patients with zygomycosis, 
a retrospective study was conducted 
during November 2001–April 2009. 
Nine patients were identiﬁ  ed as having 
primary cutaneous zygomycosis. For 
4 patients, fungal isolates were mor-
phologically identiﬁ  ed as A. elegans. 
A description of clinical ﬁ  ndings, their 
management, and outcomes for these 
9 patients has been reported (4). The 
4 isolates were sent to the Universitat 
Rovira i Virgili (Reus, Spain) for mo-
lecular analysis.
The internal transcribed spacer 
region of these isolates was sequenced 
and compared with those of type 
strains of Apophysomyces spp. Fungi 
were identiﬁ  ed by morphologic (Fig-
ure, panel A) and molecular analysis as 
A. variabilis (99.6%–99.7% sequence 
identity with sequence of type strain 
CBS 658.93 [FN556436]). GenBank 
accession nos. of the 4 isolates are 
FN813491, FN813490, FN556442, 
and FN813492.
Another patient was also infected 
with A. variabilis fungi. The patient 
was a 45-year-old woman with dia-
betes from Derabassi (Punjab), India, 
who was hospitalized because of swell-
ing in her right breast and blackening 
of overlying skin. A diagnosis of right 
breast gangrene was made. Therefore, 
local debridement of the swelling was 
conducted, and tissue samples were 
tested by microbiologic culture and 
histopathologic analysis.
A KOH wet mount showed broad 
aseptate hyphae with right-angled 
branching. The fungal isolate was 
tentatively identiﬁ  ed  as  A. elegans. 
Histopathologic analysis conﬁ  rmed 
a diagnosis of zygomycosis. The pa-
tient was treated under local anesthe-
sia by debridement of infected tissue 
and some of the healthy surrounding 
tissue (Figure, panel B). However, an 
antifungal regimen could not be given 
because she had disturbed renal func-
tion. Her condition deteriorated, sep-
ticemia was observed, and she died 
from sudden cardiac arrest on the sixth 
day after admission. The fungal iso-
late was also identiﬁ  ed as A. variabilis 
(98.9% identity, GenBank accession 
no. FN556443).
Although most cases of infection 
with  A. variabilis fungi have been 
reported in India (5), infections with 
this fungus may have a wider distribu-
tion. A recent study demonstrated that 
this species represented 0.5% of fungi 
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of the order Mucorales isolated from 
clinical samples in the United States 
(6). Furthermore, a high mortality rate 
and the fact that most of these infec-
tions involve otherwise healthy pa-
tients make this a serious infection.
The number of infections with 
Apophysomyces spp. is underestimated 
because these fungi do not usually spo-
rulate on standard fungal culture me-
dia used in clinical laboratories. These 
fungi require special nutrient-deﬁ  cient 
growth medium (Czapek agar), a high 
temperature in comparison to other 
human pathogens (37°C–42°C), and 
prolonged incubation (7–10 days) (7).
A difference in mortality rate was 
observed when we compared patients 
in our study (80%) with those reported 
by Chakrabarti et al. (5) (28.5%) in 
India, even though treatment was gen-
erally similar, i.e., local débridement 
and amphotericin B. Other differences 
in our study were that the infection in 
4 patients was preceded by intramus-
cular injection, and these 2 patients 
had diabetes mellitus.
In conclusion, A. variabilis is 
an emerging pathogenic fungus that 
can cause rapid and fatal infections 
in humans. As more isolates of Apo-
physomyces fungi become available, 
molecular typing studies must be con-
ducted to better understand the epide-
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Figure. A) Sporangiophore (center) and 
sporangiospores of Apophysomyces 
variabilis  fungi. Scale bar = 10 μm. 
B) Clinical manifestations in a woman 
infected with A. variabilis fungi in the 
upper part of the chest and the breast. 
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